BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Urgent Safety Notice for several Blood Glucose Monitoring Systems, Nipro Diagnostics

Product group In-vitro diagnostics - equipment / products for clinical chemistry
Reference 05979/13

Corrective action from Nipro Diagnostics for Blood Glucose Monitoring Systems of the TRUEtrack Private labels Wellion Smart System and STADA Gluco Check and the TRUEbalance Private label Wellion Smart System 2 due to incorrect units of measure. Customers were informed accordingly.

Urgent Safety Notice for several Blood Glucose Monitoring Systems, Nipro Diagnostics , Download_VeroeffentlichtAm_EN PDF, 112KB, File does not meet accessibility standards